Baixa dose de Whey Protein reduz glicose, triglicérides e controla o peso corporal em ratos Wistar

Jaqueline Maisa Franzen; Juliano Graciano Vaz; Vilmair Zancanaro; Rafael Mariano de Bitencourt

Jaqueline Maisa Franzen Universidade Alto Vale do Rio do Peixe
Juliano Graciano Vaz Universidade Alto Vale do Rio do Peixe
Vilmair Zancanaro Universidade Alto Vale do Rio do Peixe
Rafael Mariano de Bitencourt Universidade Alto Vale do Rio do Peixe. Universidade do Oeste de Santa Catarina

Palabras clave: Dieta proteica, Dieta de cafeteria, Obesidad, Síndrome metabólico

Resumen

Objetivo: El aumento de casos de obesidad y enfermedades metabólicas son consecuencias de una dieta desequilibrada. En este estudio, evaluamos la influencia de dosis bajas de concentrado de proteína de suero (WPC) y dieta de cafetería (CAF) en parámetros metabólicos y bioquímicos en ratas Wistar. Materiales y métodos: se utilizaron 3 grupos experimentales: control de dieta estándar (CTL), WPC de dosis baja (WPD) y dieta de cafetería (CAF), ofreciéndose dietas durante 8 semanas. Resultados: Se midió peso corporal, grasa epididimaria, Índice de Lee, Glucosa, Triglicéridos, colesterol total y fracciones, urea, creatinina, AST y ALT. Hubo una reducción significativa en glucosa (P<0.05), triglicéridos (P<0.01), control de peso corporal y ningún aumento en el Índice de Lee en el grupo WPD (P>0.05). El grupo CAF presentó resultados opuestos al grupo WPD, hubo aumento significativo de la glucosa (P<0,05), marcada ganancia de peso (P< 0,001), aumento del Índice de Lee (P<0,001) y mayor adiposidad epididimaria en relación a el grupo CTL (P<0.01) y WPD (P<0.001). Discusión: Las proteínas de suero tienen un gran potencial para controlar o prevenir enfermedades como la diabetes y la obesidad severa. Los valores de índice de Lee, grasa epididimaria, glucosa y triglicéridos fueron más bajos en el grupo WPD que en el grupo CAF al final del tratamiento. Conclusión: Las dosis bajas de WPC son efectivas para reducir la glucosa en sangre, los triglicéridos, controlar el peso corporal y pueden utilizarse como una alternativa nutricional en pacientes obesos, con sobrepeso o normales para prevenir o controlar los trastornos metabólicos y la obesidad.

Biografía del autor/a

Jaqueline Maisa Franzen, Universidade Alto Vale do Rio do Peixe

Graduanda do Curso de Farmácia da Universidade Alto Vale do Rio do Peixe; Departamento de Farmácia

Juliano Graciano Vaz, Universidade Alto Vale do Rio do Peixe

Educardor Físico, Especialista em Fisiologia do Exercício.

Vilmair Zancanaro, Universidade Alto Vale do Rio do Peixe

Farmacêutica, Especialista em Análises Clínicas; Mestranda em Ciências e Biotecnologia pela Universidade do Oeste de Santa Catarina

Rafael Mariano de Bitencourt, Universidade Alto Vale do Rio do Peixe. Universidade do Oeste de Santa Catarina

Doutor em Farmacologia pela Universidade Federal de Santa Catarina - UFSC

Citas

-Akhavan, T.; Luhovyy, B.L.; Brown, P.H.; Cho, C.E.; Anderson, G.H. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. The American journal of clinical nutrition. Vol. 91. Núm. 4. p. 966-975. 2010.

-Ang, M.; Müller, A.S.; Wagenlehner, F.; Pilatz, A.; Linn, T. Combining protein and carbohydrate increases postprandial insulin levels but does not improve glucose response in patients with type 2 diabetes. Metabolism. Vol. 61. Núm. 12. p. 1696-1702. 2012.

-Bernardis, L. L.; Patterson, B. D. Correlation between' Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. Journal of Endocrinology. Vol. 40. Núm. 4. p. 527-528. 1968.

-Bortolotti M.; Maiolo E.; Corazza M.; Van Dijke E.; Schneiter P.; Boss A.; Carrel G.; Giusti V.; Lê K.A.; Chong D.G. Q.; Buehler T.; Kreis R.; Boesch C.; Tappy L. Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clinical Nutrition. Vol. 30. Núm. 4. p. 494-498. 2011.

-Brennan, I.M.; Luscombe-Marsh, N.D.; Seimon, R.V.; Otto, B.; Horowitz, M.; Wishart, J.M; Feinle-Bisset, C. Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men. American Journal of Physiology-Gastrointestinal and Liver Physiology. Vol. 303. Núm. 1. p. G129-G140. 2012.

-Chelikani, P.K.; Haver, A.C.; Heidelberger, R.D. Intravenous infusion of peptide YY (3–36) potently inhibits food intake in rats. Endocrinology. Vol. 146. Núm. 2. p. 879-888. 2005.

-Cota, D.; Marsicano, G.; Lutz B.; Vicennati, V.; Stalla, G.K.; Pasquali, R.; Pagotto, U. Endogenous cannabinoid system as a modulator of food intake. International journal of obesity. Vol. 27. Núm. 3. p. 289-301. 2003.

-Cummings, D.E.; Purnell, J.Q.; Frayo, R.S.; Schmidova, K.; Wisse, B.E.; Weigle, D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. Vol. 50. Núm. 8. p. 1714-1719. 2001.

-De Andrade, I. S.; Zemdegs, J. C. S.; de Souza, A. P.; Watanabe, R. L. H.; Telles, M. M.; Nascimento, C. M. O.; Ribeiro, E. B. Diet-induced obesity impairs hypothalamic glucose sensing but not glucose hypothalamic extracellular levels, as measured by microdialysis. Nutrition & diabetes. Vol. 5. Núm. 6. p. 162. 2015.

-Estadella, D.; Oyama, L. M.; Dâmaso, A. R.; Ribeiro, E. B.; Do Nascimento, C. M. O Effect of palatable hyperlipidic diet on lipid metabolism of sedentary and exercised rats. Nutrition. Vol. 20. Núm. 2. p. 218-224. 2004.

-Estadella D.; Oyama L. M.; Bueno A. A.; Habitante C. A.; Souza G. I.; Ribeiro E. B.; Motovama C. S. M.; Oller, C. M. N. A palatable hyperlipidic diet causes obesity and affects brain glucose metabolism inrats. Metabolism. Vol. 16. p. 18-20. 2011.

-Friedewald, W. T.; Levy, R. I.; Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. Vol. 18. Núm. 6. p. 499-502. 1972;

-Gad, A. S.; Khadrawy, Y.; El-Nekeety, A.; Mohamed, S. R.; Hassan, N. S.; Abdel-Wahhab, M. Antioxidant activity and hepatoprotective effects of whey protein and Spirulina in rats. Nutrition. Vol. 27. Núm. 5. p. 582-589. 2011.

-Gallate,J. E.; Saharov, T.; Mallet, P. E.; McGregor, I. S. Increased motivation for beer in rats following administration of a cannabinoid CB 1 receptor agonist. European journal of pharmacology. Vol. 370. Núm. 3. p. 233-240. 1999.

-Gaudel, C.; Nongonierma, A. B.; Maher, S.; Flynn, S.; Krause, M.; Murray, B. A.; Newsholme, P. A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice. The Journal of nutrition. Vol. 143. Núm. 7. p. 1109-1114. 2013.

-Gessa, G.; Melis, M.; Muntoni, A.; Diana, M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB 1 receptors. European journal of pharmacology. Vol. 341. Núm. 1. p. 39-44. 1998.

-Gillespie, A. L.; Calderwood, D.; Hobson, L.; Green, B. D. Whey proteins have beneficial effects on intestinal enteroendocrine cells stimulating cell growth and increasing the production and secretion of incretin hormones. Food Chemistry. Vol. 189. p. 120-128. 2015.

-Hoefle, A. S.; Bangert, A. M.; Stamfort, A.; Gedrich, K.; Rist, M. J.; Lee, Y.; Skurk T,; Daniel H. Metabolic Responses of Healthy or Prediabetic Adults to Bovine Whey Protein and Sodium Caseinate Do Not Differ. The Journal of nutrition. Vol. 145. Núm. 3. p. 467-475. 2015.

-Heymsfield, S. B.; Greenberg, A. S.; Fujioka, K.; Dixon, R. M.; Kushner, R.; Hunt, T.; Lunina J. A.; Patane J.; Self B.; Hunt P.; McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Jama. Vol. 282. Núm. 16. p. 1568-1575. 1999.

-Jonker, R.; Deutz, N. E.; Erbland, M. L.; Anderson, P. J.; Engelen, M. P. Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion.Clinical Nutrition. Vol. 33. Núm. 2. p. 211-220. 2014.

-Lacroix,I. M. E.; Li-Chan,E. C. Y. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. International Dairy Journal. Vol. 25. Núm. 2. p. 97-102. 2012.

-Lustig, R. H. The neuroendocrinology of obesity. Endocrinology and metabolism clinics of North America, Vol. 30. Núm. 3. p. 765-785, 2001.

-Macedo, I. C.; Medeiros, L. F.; Oliveira, C.; Oliveira, C. M.; Rozisky, J. R.; Scarabelot, V. L.; Souza A.; Silva F. R.; Santos V. S.; Cionato S. G.; Caumo W.; Torres I. L. S.; Cafeteria diet-induced obesity plus chronic stress alter serum leptin levels. Peptides. Vol. 38. Núm. 1. p. 189-196. 2012.

-Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. Vol. 346. Núm. 6284. p. 561-564. 1990.

-McAllan, L.; Keane, D.; Schellekens, H.; Roche, H. M.; Korpela, R.; Cryan, J. F.; Nilaweera, K. N. Whey protein isolate counteracts the effects of a high-fat diet on energy intake and hypothalamic and adipose tissue expression of energy balance-related genes. British Journal of Nutrition. Vol. 110. Núm. 11. p. 2114-2126. 2013.

-Meeran, K.; O’Shea, D.; Edwards, C. M. B.; Turton, M. D.; Heath, M. M.; Gunn, I., Abusnana, S.; Rossi, M.; Small, C. J.; Goldstone, A. P.; Taylor, G.M.; Sunter, D.; Steere, J.; Choi, S. J.; Ghtei, M. A.; Bloom,S. R.Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7–36) Amide or Exendin-(9–39) Alters Body Weight in the Rat 1. Endocrinology. Vol. 140. Núm. 1. p. 244-250. 1999.

-Morato, P. N.; Lollo, P. C.; Moura, C. S.; Batista, T. M.; Camargo, R. L.; Carneiro, E. M.; Amaya-Farfan, J. Whey protein hydrolysate increases translocation of GLUT-4 to the plasma membrane independent of insulin in wistar rats. PloS one. Vol. 8. Núm. 8. p. 7. 2013.

-Morris, M. J.; Chen, H.; Watts, R.; Shulkes, A.; Cameron-Smith, D.; Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet. International journalof obesity. Vol. 32. Núm. 2. p. 249-258. 2008.

-Münzberg, H.; Flier, J. S.; Bjørbæk, C. Christian. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology. Vol. 145. Núm. 11. p. 4880-4889. 2004.

-Nielsen, L. L.; Young, A. A.; Parkes, D. G. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regulatory peptides, Vol. 117. Núm. 2. p. 77-88, 2004.

-Noatsch, A.; Petzke, K. J.; Millrose, M. K.; Klaus, S. Body weight and energy homeostasis was not affected in C57BL/6 mice fed high whey protein or leucine-supplemented low-fat diets. European journal ofnutrition. Vol. 50. Núm. 6. p. 479-488. 2011.

-Ooi, E. M.; Adams, L. A.; Zhu, K.; Lewis, J. R.; Kerr, D. A.; Meng, X.; Solah V. Devine A.; Binns C.W.; Prince, R. L. Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women.Nutrition, Metabolism and Cardiovascular Diseases. Vol. 25. Núm. 4. p. 388-395. 2015.

-Panahi, S.; El Khoury, D.; Kubant, R.; Akhavan, T.; Luhovyy, B. L.; Goff, H. D.; Anderson, G. H. Mechanism of action of whole milk and its components on glycemic control in healthy young men. The Journal of nutritional biochemistry, Vol. 25. Núm. 11. p. 1124-1131. 2014.

-Pasiakos, S. M.; Lieberman, H. R.; Fulgon,i V. L. Higher-Protein Diets Are Associated with Higher HDL Cholesterol and Lower BMI and Waist Circumference in US Adults. The Journal of nutrition. Vol. 25. Núm. 1. p. 1124-1131. 2015.

-Sanchis-Segura, C.; Cline, B. H.; Marsicano, G.; Lutz, B.; Spanagel, R. Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology. Vol. 176. Núm. 2. p. 223-232. 2004.

-Tahavorgar, A.; Vafa, M.; Shidfar, F.; Gohari, M.; Heydari, I. Whey protein preloads are more beneficial than soy protein preloads in regulating appetite, calorie intake, anthropometry, and body composition of overweight and obese men. Nutrition Research. Vol. 34. Núm. 10. p. 856-861. 2014.

-Ting, C. H.; Chi, C. W.; Li, C. P.; Chen, C. Y. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats. Nutrition. Vol. 31. Núm.1. p. 230-235. 2015.

-Trillou, C. R.; Delgorge, C.; Menet, C.; Arnone, M.; Soubrie, P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. International journal of obesity. Vol. 28. Núm. 4. p. 640-648. 2004.

-Tranberg, B.; Madsen, A. N.; Hansen, A. K.; Hellgren, L. I. Whey-reduced weight gain is associated with a temporary growth reduction in young mice fed a high-fat diet. The Journal of nutritional biochemistry. Vol. 26. Núm. 1. p. 9-15. 2015.

-Tschöp, M.; Smiley, D. L.; Heiman, M. L. Ghrelin induces adiposity in rodents. Nature. Vol. 407. Núm. 6806. p. 908-913, 2000.

-Vähätalo, L. H.; Ruohonen, S. T.; Mäkelä, S.; Ailanen, L.; Penttinen, A. M.; Stormi, T.; Kauko T.; Piscitelli, F.; Silvestri, C.; Savontaus, E.; Di Marzo, V. Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons.Nutrition & diabetes. Vol. 5. Núm. 4. p. 151. 2015.

-Valassi, E.; Scacchi, M.; Cavagnini, F. Neuroendocrine control of food intake. Nutrition, metabolism and cardiovascular diseases. Vol. 18. Núm. 2. p. 158-168. 2008.

-Zhou, D.; Shearman, L. P. Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacology Biochemistry and Behavior. Vol. 77. Núm. 1. p. 117-125. 2004.

Dosis bajas de Whey Protein reducen la glucosa, los triglicéridos y controlan el peso corporal en ratas Wistar

Resumen

Biografía del autor/a

Citas